Intellia Therapeutics, Inc. (NTLA) NASDAQ

8.70

+0.03(+0.35%)

Updated at November 14 04:00PM

Currency In USD

Valuation

Market Cap1.15B
Enterprise Value1.17B
P/E Ratio-2.15
PEG Ratio-0.24
Price/Sales Ratio15.85
Price/Book Ratio1.28
Enterprise/Revenue14.19
Enterprise/EBITDA-2.27

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-7.75
Operating Margin-6.38

Management Effectiveness

Return On Assets-0.48
Return On Equity-0.57

Income Statement

Revenue57.88M
Revenue/Share0.52
Gross Profit47.59M
EBITDA-523.98M
Net Income-519.02M
Diluted EPS-5.25

Balance Sheet

Total Cash511.04M
Total Cash/Share4.64
Total Debt97.97M
Total Debt/Equity0.13
Current Ratio6.21
Book Value Per Share6.79

Price History

52-Week Change-38.6
52-Week High28.25
52-Week Low5.9
Moving Average 50 Days16.96
Moving Average 200 Days11.51

Statistics

Average Volume7.83M
Shares Outstanding104.79M
% Held by Institutions99.51

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A